D. Meise

发表

Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis

S. Jugl, K. Krüger, F. Meier, 2018, Rheumatology International.

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany

A. Canbay, J. Sowa, A. Ozbay, 2021, Annals of translational medicine.

Economic burden of secondary hyperparathyroidism in Germany: a matched comparison

E. Seibert, H. Reichel, K. M. Schneider, 2022, International Urology and Nephrology.

Health Resource Utilization and Associated Health Care Costs of Biologic Disease‐Modifying Antirheumatic Drugs in German Patients With Psoriatic Arthritis

Matthias Schneider, J. Mahlich, P. Sewerin, 2021, Arthritis care & research.

Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study

Matthias Schneider, J. Mahlich, P. Sewerin, 2021, Rheumatology and Therapy.

Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis.

H. Orzechowski, C. Fiehn, D. Meise, 2023, Zeitschrift für Rheumatologie (Print).

Patterns and predictors of mortality and disease progression among patients with non‐alcoholic fatty liver disease

A. Canbay, J. Sowa, A. Ozbay, 2020, Alimentary pharmacology & therapeutics.

A comparative assessment of neutropenia events, healthcare resource use, and costs among cancer patients treated with lipegfilgrastim compared with pegfilgrastim in Germany

H. Link, D. Meise, S. Thompson, 2022, Supportive Care in Cancer.

Substantial comorbidities and rising economic burden in real-world non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) patients with compensated cirrhosis (CC): A large German claims database study

A. Canbay, D. Meise, J. Haas, 2018 .